Antacids used to decrease phosphorus absorption in patients with renal failure may be toxic. To find more efficient or less toxic binders, a three-part study was conducted. First, theoretical calculations showed that phosphorus binding occurs in the following order of avidity: Al3+ greater than H+ greater than Ca2+ greater than Mg2+. In the presence of acid (as in the stomach), aluminum can therefore bind phosphorus better than calcium or magnesium. Second, in vitro studies showed that the time required to reach equilibrium varied from 10 min to 3 wk among different compounds, depending upon solubility in acid and neutral solutions. Third, the relative order of effectiveness of binders in vivo was accurately predicted from theoretical and in vitro results; specifically, calcium acetate and aluminum carbonate gel were superior to calcium carbonate or calcium citrate in inhibiting dietary phosphorus absorption in normal subjects. We concluded that: (a) inhibition of phosphorus absorption by binders involves a complex interplay between chemical reactions and ion transport processes in the stomach and small intestine; (b) theoretical and in vitro studies can identify potentially better in vivo phosphorus binders; and (c) calcium acetate, not previously used for medical purposes, is approximately as efficient as aluminum carbonate gel and more efficient as a phosphorus binder than other currently used calcium salts.
Introduction
In chronic renal failure, phosphorus retention plays a major role in the development of secondary hyperparathyroidism and osteodystrophy (1) (2) (3) (4) (5) (6) . To prevent phosphorus retention, various aluminum-containing antacids have been used to bind phosphorus within the gastrointestinal tract and thus prevent its absorption. Unfortunately, long-term use of aluminum compounds by patients with chronic renal failure is associated with risk of serious aluminum toxicity (7) (8) (9) (10) (11) (12) . This has prompted the search for safer phosphorus binders. Calcium carbonate and calcium citrate are two such candidates (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) ; however, large doses are often required, and hypercalcemia is therefore a potential complication.
In an attempt to understand the process of phosphorus binding and to find more efficient binder(s) with less toxicity, a three-part study was carried out. First, we calculated the binding that theoretically would occur at equilibrium when different binders and phosphorus are mixed in ratios similar to those used clinically. Second, we performed in vitro experiments to evaluate the time required for twelve different compounds to reach equilibrium. And third, since conditions in the gut may differ from some conditions in vitro, we measured the extent to which several selected binders inhibit dietary phosphorus absorption in normal people.
Methods
Definition ofphosphorus binding. Phosphorus binding is either a chemical reaction between dietary phosphorus and cation of the binder compound, resulting in the formation of insoluble and hence unabsorbable phosphate compounds (23) , adsorption of phosphorus ions on the surface of binder particles (24, 25) , or a combination of both processes (26) . The operational definition of phosphorus binding varies in the three parts of this study. In the theoretical calculations, binding is defined as formation ofinsoluble solid phosphate(s). For the in vitro experiments, the amount of phosphorus that did not pass through a millipore filter was regarded as bound by the binder. For the in vivo experiments, binding was defined as reduction in gastrointestinal phosphorus absorption when the binder was ingested with a test meal.
Relative amounts ofbinder and phosphorus. For most of the theoretical calculations and in vitro experiments, we used 75 meq ofbinder cation (i.e., 1,500 mg of calcium, 675 mg of aluminum, or 900 mg of magnesium) and 320 mg of elemental phosphorus (equal to 10-31 meq of phosphate depending upon pH) in a volume of 600 ml. These amounts are identical to the dose of binder, phosphorus content, and volume ofa test meal in a recent in vivo study (27) . For the in vivo part of the study, 50 meq of binder and 345 mg (1 1-33 meq) of meal phosphorus were used. This reduced binder dose was used in the in vivo study because higher doses are not likely to be used clinically on a chronic basis for fear of toxicity. To better compare the in vivo and in vitro results, the binders used in the in vivo studies were also studied at the lower dose in vitro.
Binders studied. In the theoretical and in vitro parts ofthe study the following binders were studied: calcium chloride, calcium acetate, calcium lactate, calcium gluconate, calcium citrate, calcium carbonate, aluminum chloride, aluminum hydroxide powder, magnesium hydroxide (all reagent grade), aluminum hydroxide gel (Amphojel; Wyeth Laboratories, Philadelphia, PA), aluminum carbonate gel (Basaljel suspension; Wyeth Laboratories), and sucralfate (a-D-glucopyranoside, a-D-fuctofuranosyl-octakis-(hydrogen sulfate), aluminum complex, Carafate; Marion Laboratories, Kansas City, MO). In the in vivo part of the study, the following binders were studied: calcium carbonate, calcium citrate, calcium acetate, and aluminum carbonate gel (Basaljel suspension).
Part k Theoreticalphosphorus binding at equilibrium. From knowledge of equilibrium constant expressions (28) equilibrium constants were also considered in the system of equations solved for determining total phosphate. For these calculations, the effect ofionic strength was ignored and activity coefficients were assumed to be unity. Percent binding was calculated as precipitated phosphate divided by total phosphate times 100.
The binding of phosphorus by calcium chloride at pH 4 will be taken as an example. The initial total phosphate concentration was 0.0172 M (or 320 mg/600 ml) and that ofCa2' was 0.0625 M (or 1,500 mg/600 ml). From the equilibrium constant expressions (28) Net phosphorus and calcium absorption was measured by a method described in detail and validated previously (31, 27) . The subject entered the laboratory after an 8-h fast. The entire gastrointesti-nal tract was cleansed by lavage with a poorly absorbed solution. 4 h after the lavage was completed, the subject ingested one halfofthe total dose of placebo or binder with 100 ml of deionized water. Then the subject ate the meal. Immediately thereafter, the second half of the dose of placebo or binder was ingested with 100 ml ofwater. 10 h after starting the meal, a second lavage was started. This removed unabsorbed material from the gut. Calcium and phosphorus content of the rectal effluent was measured.
Absorption was calculated according to the following equation: Net phosphorus absorption = phosphorus intake -(effluent phosphorus after placebo/binder -effluent phosphorus after fast).
Phosphorus intake is equal to the phosphorus content of the duplicate meal. Calcium absorption is calculated similarly except that calcium intake is the sum of the calcium content of the duplicate meal and the binder.
Test meal and rectal effluent were analyzed for phosphorus by the method of Fiske and Subbarow (30) and for calcium by atomic absorption spectroscopy. PEG was analyzed by the method of Hyden (32).
Results
Part I: Theoretical phosphorus binding at equilibrium. Fig. 1 shows calculated binding at equilibrium at different pH levels for aluminum, calcium, and magnesium compounds. At equilibrium the aluminum compounds bind 100% of the phosphorus in the pH range 3.5-7.5. Above pH 7.5, the binding drops (to 96% at pH 8) due to precipitation of Al(OH)3. For calcium compounds (except calcium citrate) and for magnesium compounds the binding is -100% at pH levels > 5.5 and 6.0, respectively. Binding drops to 0% at pH 3.5 for calcium compounds (except calcium citrate for which the binding drops to 0% at pH 4.5) and to 0% at pH 4.0 for magnesium compounds. This happens because at low pH, where hydrogen ion concentration is high, H+ competes for phosphorus more effectively than calcium or magnesium. (By contrast, aluminum competes effectively with H+ so that binding is 100% even at low pH.) As shown in Fig. 1 , < pH 5.5 calcium binds phosphorus more effectively than magnesium. Thus, < pH 6 the theoretical order of avidity for reaction with phosphorus (excluding calcium citrate) is A131 > HI > Ca2+ > Mg2e.
Citrate, in contrast to anions of other calcium compounds used in our experiments, forms soluble complexes with calcium (33) ; this reduces the availability of calcium for reaction with phosphorus. This is particularly evident at low pH. With rising pH, the phosphate species change from H2PO4 to HP042-to P043-. The latter species have much smaller solubility product constants with calcium (28) and can thus effectively compete with citrate; therefore, phosphorus binding is higher in the higher pH range. Fig. 4 shows the in vitro phosphorus binding at 1, 4, and 10 h with 50 meq amount of the four binders used in the in vivo studies; the amount of phosphorus used in these experiments was 320 mg. The results are qualitatively similar to those in part II (Figs. 2  and 3) . Table I shows the individual and mean data for phosphorus absorption on the various test days. PEG recoveries on different test days were 98-100% as shown in the footnote to Table I . As compared with the placebo, all binders reduced phosphorus absorption significantly (P < 0.001 by analysis of variance). By Fisher's least significant difference test for multiple comparisons (35) , the difference between aluminum carbonate gel and calcium acetate is not statistically significant, and phosphorus absorption with these two compounds is significantly less than that with calcium carbonate and calcium citrate (P < 0.01 in all instances); the difference between the latter two compounds is not statistically significant.
Calcium absorption after ingestion of placebo and the three calcium salts is shown in Table II with placebo, calcium absorption was significantly higher with calcium salts (P < 0.001 by analysis of variance). By Fisher's least significant difference test for multiple comparisons, calcium absorption from calcium acetate was significantly less than that from calcium carbonate (P < 0.05) and from calcium citrate (P < 0.05); the difference between the latter two compounds was not statistically significant. After ingestion of the three calcium salts, mean values for calcium absorption and inhibition of phosphorus absorption were inversely correlated (r = -0.997, P < 0.005). Thus, the calcium salt that best inhibited phosphorus absorption (calcium acetate) was associated with the least calcium absorption. Discussion Binding at equilibrium. The results of the calculations based on equilibrium constants show that binding at equilibrium depends upon the binder used, pH, and presence ofcompeting anions. In the absence of competing anions, aluminum compounds bind better than calcium compounds that in turn bind better than magnesium compounds (Fig. 1) . These differences between different binders are due to their different inherent abilities to react with phosphorus, as expressed by the equilibrium constants for the various reactions. The extent to which aluminum compounds are better than calcium and magnesium compounds is dependent on pH; at low pH the difference is striking, whereas at high pH it is negligible. The dramatic fall in binding by calcium and magnesium compounds at low pH is mainly due to the fact that high concentrations of H' effectively compete with calcium and magnesium for phosphorus. Aluminum, on the other hand, can effectively compete with H' for phosphorus and thus is just as effective at low as at high pH. The presence of anions that compete with phosphorus for there is greater complex formation at higher pH in the absence the binder cation decreases phosphorus binding. For instance, of phosphorus (33) . Nevertheless, the phosphate species at citrate ion forms a strong complex with calcium (33) 340  271  156  344  187  244  346  228  205  356  315  128  2  58  343   114  287  353  359  52  352  272  138  346  225  179  344  449 -47   3  73  353  186 240  358  386  45  328  285  116  319  268  124  359  381  51  4   50  323  147   226  325  346  29  319   271  98  354  254  150  352  384  18  5  64  336  116 284  345  223  186  360  266  158  322  176  210  351  367  48  6  52  338  105 285  340  318   74   339  243  148  362  232  182  357  318  91  7   60  357  151  266  362  306  116  352  280  132  345  270  135  362  306  116  8  96  344  159 281  347  355  88  345  288  153  345  285  156  333  319  110  9   54  346  194 206  324  353  25  366  296  124  352  290  116  330  353  31  10  85  322  123 284  352  320  117  363  245  203  359  194  250  327  348  64  Mean  68  342  147  263  345  324  89  347  263  151  345  242  171  347  354  61   ±SEM  ±5  ±4  ±10  ±9  ±4  ±15  ±17  ±5  ±10 ±14  ±4  ±12  ±13  ±4  ±14 ±17 achieved in vitro. Aluminum hydroxide powder bound far less phosphorus than theoretical equilibrium values (Fig. 3) ; this probably can be attributed to its extreme insolubility and slow dissolution (36) . If enough time was allowed, equilibrium values would probably be achieved with aluminum hydroxide powder, since aluminum hydroxide in the form of a gel did approach theoretical equilibrium values in 1-3 wk (Fig. 3) . Rate of establishment of equilibrium in vitro. The rate at which equilibrium is established depends upon the rate at which the binders dissolve and the rate of the precipitation reaction between ionized binder cation and phosphorus. Because the latter is virtually instantaneous for the compounds involved, the rate of dissolution of binders controls the rate at which equilibrium is established. The rate at which binder dissolves in a given medium depends mainly upon water solubility, pH, amount of binder, the rate ofstirring, and temperature.
Freely water-soluble compounds dissolve readily thus making all the binder available for reaction. In the case of poorly soluble compounds, however, only a small amount slowly gets dissolved. As this small amount ofdissolved binder reacts with phosphorus, the concentration of dissolved binder falls, which in turn allows further dissolution. This process continues until equilibrium is reached. It follows that freely soluble compounds would reach equilibrium quickly, whereas poorly soluble compounds would take a longer time. It is therefore not surprising that highly soluble calcium chloride reached equilibrium within 10 min and calcium acetate and aluminum chloride (Figs. 2 and 3 ) reached equilibrium within 1 h (the earliest time tested), whereas poorly soluble calcium carbonate, calcium citrate and magnesium hydroxide (Figs. 2  and 3 ) took 1-2 wk to approach equilibrium at pH 7 (where concentration of H' is not enough to enhance solubility).
The pH of the medium affects solubility of the binders. Calcium carbonate, for example, is much more soluble at low pH; thus at pH 5 equilibrium was approached at 4 h, whereas at pH 7 equilibrium was reached only at 1 week (Fig. 2) . A similar effect was seen with aluminum carbonate gel where at pH 4 equilibrium value was reached between 24 h and 1 wk, whereas at pH 7 equilibrium value was approached only at 3 wk. At pH 2-3, aluminum carbonate gel would probably approach equilibrium even earlier than 24 h, although we did not perform in vitro experiments at such high levels of acidity.
Correlation ofin vitro and in vivo phosphorus binding. To reduce dietary phosphorus absorption, a binder must mix with food and precipitate or adsorb meal phosphorus before phosphorus and the binder are absorbed by the small intestine. The mixing of food phosphorus and the binder can occur in the stomach and upper small intestine as food phosphorus is readily solubilized in the upper gastrointestinal tract (37) . Because most of phosphorus is believed to be absorbed by the small intestine (38) , and since most of ingested food passes through the stomach and small intestine in 4-6 h (39) (Fig. 4) . At pH 6-7 (corresponding to the pH of the jejunum and ileum), 50 meq of calcium acetate is expected to bind 98% of the 320 mg phosphorus in 1 h, leaving 6 mg unbound. Calcium acetate thus inhibited food phosphorus absorption in the intestine less well than it bound phosphorus in a beaker. Several possible explanations may be offered to explain this difference, including incomplete mixing of food phosphorus and binder calcium, absorption of phosphorus and/or calcium in the small bowel before binding could occur, the slightly acid environment ofthe duodenum (40) , which would reduce binding but not phosphorus absorption, and partial conversion of soluble calcium into poorly soluble salts in the small intestine.
At pH 6-7 in vitro, calcium acetate was far superior to calcium carbonate as a phosphorus binder (Fig. 4) . For example, after 4 h at -pH 6 calcium carbonate bound -30% (96 mg) of phosphorus in the beaker compared with 98% binding (314 mg) by calcium acetate (Fig. 4) . Calcium acetate was also superior to calcium carbonate at inhibiting phosphorus absorption in vivo but the difference was not as great (see Table  I ). The most likely explanation for this observation is partial conversion of calcium carbonate by gastric acid to calcium chloride (CaCO3 + 2HC1-* CaCl2 + H20 + CO2), which can then bind phosphorus as the pH rises in the small intestine.
In vitro phosphorus binding by calcium citrate was poor compared with other calcium salts, including calcium carbonate. However, calcium citrate was only slightly less effective than calcium carbonate in vivo. One possible explanation for this finding is intestinal absorption of citrate, thus minimizing complex formation between calcium and citrate that would otherwise have prevented phosphorus binding.
As compared to calcium carbonate and calcium citrate, calcium acetate bound more phosphorus but less calcium was absorbed from it. There can be two explanations for this observation. First, less calcium could have been absorbed from calcium acetate and hence more was available in the intestine to bind phosphorus. Second, more calcium from calcium acetate could have reacted with food phosphorus and hence less was available to be absorbed. The first explanation is probably not correct, because in a recent study, calcium absorption was observed to be similar from these calcium salts when ingested without concomitant ingestion of food (41); hence, the second explanation is more likely to be correct. As is evident from Table I , calcium acetate bound 62 mg (151 minus 89) more phosphorus as compared with calcium carbonate. This amount of phosphorus is equal to 3.6 meq (assuming the valence of phosphorus in the gut to be 1.8 as suggested by Lennon et al. [42] ), and should be bound by 3.6 meq or 72 mg of calcium. Thus with calcium acetate 72 mg less calcium was presumably available to be absorbed as compared with calcium carbonate. As is evident from Table II calcium absorption from calcium acetate was 61 mg (or 3.1 meq) lower as compared with calcium carbonate, a value in close agreement with that expected from the degree of phosphorus binding by these two compounds.
For clinical purposes, one would like for a phosphorus binder to bind as much phosphorus as possible, and for residual binder to be absorbed as little as possible (in order to avoid toxicity). We found that calcium acetate bound 1.04±0.11 mg phosphorus/mg of calcium absorbed (calculated from data for individual subjects, Tables I and II) , which is significantly better than calcium carbonate (0.57±0.15, P < 0.05) and calcium citrate (0.43±0.07, P < 0.001). Thus, by this method of analysis, calcium acetate has about a twofold advantage over the other calcium salts.'
